MabGenesis

About:

MabGenesis is a biotechnology firm that provides therapeutic monoclonal antibody drugs.

Top Investors: SMBC Venture Capital, Beyond Next Ventures, ANNIVERSAIRE, The Miyazaki Bank

Description:

MabGenesis is a biopharmaceutical company that provides therapeutic monoclonal antibody drugs in human and animal fields. They have antibody library and monoclonal antibody isolation technology. With the provision of novel antibody therapeutics, the firm helps to relieve symptoms and improve the quality of life of individuals suffering from diseases and their companion animals.

Total Funding Amount:

278M JPY

Headquarters Location:

Yokohama, Kanagawa, Japan

Founded Date:

2019-06-03

Founders:

Katsuhiro Shinjo

Number of Employees:

1-10

Last Funding Date:

2020-06-01

IPO Status:

Private

Industries: